A new approach to fragment-based drug design
Researchers in the US and Germany have developed a metallofragment library for fragment-based drug discovery. As the first of its kind, this library could help medicinal chemists access drug leads with underexplored three-dimensional shapes that are more likely to interact with biological targets.